News
Inovio Pharmaceuticals
INO · NASDAQ
$1.01+$0.01 (+1.00%)TodayMarket closed ·
Prev close $1.00
Latest news
- Press releasePRNewswire
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
- Press releasePRNewswire
INOVIO to Participate in Upcoming Investor Conferences
- News
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
- Press releasePRNewswire
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- Press releasePRNewswire
INOVIO to Report Second Quarter Financial Results on August 12, 2026
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsTanya Rawat
Inovio Stock Falls 21% After Hours: Here's What's Going On
- Press releasePRNewswire
INOVIO Announces Pricing of $20.0 Million Public Offering
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releasePRNewswire
INOVIO Announces Proposed Public Offering
- Press releasePRNewswire
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm
- Press releaseGlobe Newswire
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm
- Press releasePRNewswire
INOVIO to Participate in Upcoming Scientific and Investor Conferences
- News
Inovio Pharmaceuticals' Partner For VGX-3100 In China, ApolloBio, Announces Topline Results From Its Pivotal Phase 3 Trial Of VGX-3100; Trial Met Its Predefined Primary Efficacy Endpoint And Demonstrated An Overall Favorable Safety And Tolerability Profile
- Press releasePRNewswire
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
- News
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call
- Press releasePRNewswire
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
- News
Earnings Scheduled For May 13, 2026
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releasePRNewswire
INOVIO to Participate in Upcoming Scientific Conferences
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
INOVIO to Report First Quarter Financial Results on May 13, 2026
- Press releaseGlobe Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
- Press releasePRNewswire
INO Deadline Today: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
- Press releaseGlobe Newswire
DEADLINE ALERT for PSFE, INO, KD: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
- Press releaseBusiness Wire
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
- Press releaseBusiness Wire
INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026
- NewsVandana Singh
What's Going On With Inovio Pharmaceuticals Stock On Tuesday?
- Press releasePRNewswire
INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7th
- Press releaseBusiness Wire
Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
- Press releasePRNewswire
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
- Press releasePRNewswire
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
- NewsAvi Kapoor
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.